Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
10.48
+0.26 (2.54%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Orthofix Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 833.19 | 822.31 | 799.49 | 746.64 | 460.71 | 464.48 |
Revenue Growth | 2.99% | 2.85% | 7.08% | 62.06% | -0.81% | 14.25% |
Gross Profit Gross Profit Growth | 593.73 | 576.88 | 558.07 | 522.32 | 337.17 | 349.57 |
Operating Income Operating Income Growth | -37.56 | -57.61 | -65.53 | -105.77 | -30.47 | -0.13 |
Net Income Net Income Growth | -61.72 | -92.19 | -126 | -151.4 | -19.75 | -38.38 |
Earnings Per Share EPS Growth | -1.53 | -2.33 | -3.30 | -4.12 | -0.98 | -1.95 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Global Limb Reconstruction Global Limb Reconstruction Growth | 142.1 | 134.66 | 124.18 | 115.32 | 107.54 | 105.52 |
Global Spine Global Spine Growth | 691.09 | 687.66 | 675.31 | 631.32 | 353.17 | 358.96 |
Total Total Growth | 833.19 | 822.31 | 799.49 | 746.64 | 460.71 | 464.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 103.81 | 82.03 | 83.24 | 33.11 | 50.7 | 87.85 |
Total Debt Total Debt Growth | 261.9 | 203.85 | 193.71 | 134.2 | 26.91 | 25.76 |
Net Cash (Debt) Net Cash Growth | -158.09 | -121.82 | -110.47 | -101.09 | 23.8 | 62.09 |
Net Cash Growth | - | - | - | - | -61.68% | -9.23% |
Net Cash Per Share Net Cash Per Share Growth | -3.92 | -3.08 | -2.90 | -2.75 | 1.19 | 3.15 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 16.27 | 33.35 | 25.79 | -45.75 | -11.54 | 18.48 |
Capital Expenditures CapEx Growth | -44.09 | -34.63 | -34.88 | -62.05 | -23.16 | -17.79 |
Free Cash Flow Free Cash Flow Growth | -27.82 | -1.28 | -9.09 | -107.8 | -34.7 | 0.69 |
Free Cash Flow Growth | - | - | - | - | - | -98.66% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.26% | 70.15% | 69.80% | 69.96% | 73.18% | 75.26% |
Operating Margin | -4.51% | -7.01% | -8.20% | -14.17% | -6.61% | -0.03% |
Pretax Margin | -7.24% | -11.04% | -15.49% | -19.91% | -3.84% | -2.91% |
Profit Margin | -7.41% | -11.21% | -15.76% | -20.28% | -4.29% | -8.26% |
FCF Margin | -3.34% | -0.16% | -1.14% | -14.44% | -7.53% | 0.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 26.70 | 22.03 | 22.03 | 21.88 | 35.26 |
P/FCF Ratio | - | - | - | - | - | 889.68 |
PS Ratio | 0.51 | 0.73 | 0.84 | 0.66 | 0.89 | 1.32 |